Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 9

1.

Imaging prostate cancer lymph node metastases with a multimodality contrast agent.

Hall MA, Kwon S, Robinson H, Lachance PA, Azhdarinia A, Ranganathan R, Price RE, Chan W, Sevick-Muraca EM.

Prostate. 2012 Feb 1;72(2):129-46. doi: 10.1002/pros.21413. Epub 2011 May 2.

PMID:
21538422
2.

Positron emission tomography for prostate, bladder, and renal cancer.

Schöder H, Larson SM.

Semin Nucl Med. 2004 Oct;34(4):274-92. Review.

PMID:
15493005
3.

Pelvic lymph node dissection in prostate cancer.

Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE.

Eur Urol. 2009 Jun;55(6):1251-65. doi: 10.1016/j.eururo.2009.03.012. Epub 2009 Mar 10. Review.

PMID:
19297079
4.

[Value of imaging for lymph node metastases from renal cell, bladder, prostate, penile, and testicular cancers].

Stattaus J, Bockisch A, Forsting M, Müller SP.

Urologe A. 2005 Jun;44(6):614-24. Review. German.

PMID:
15905989
5.

64Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated IRDye 800CW (a near-infrared fluorescence dye) coupled to mAb7, an anti-epithelial cell adhesion molecule monoclonal antibody.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2013 Mar 05 [updated 2013 Apr 11].

6.

Molecular and functional imaging for detection of lymph node metastases in prostate cancer.

Fortuin A, Rooij Md, Zamecnik P, Haberkorn U, Barentsz J.

Int J Mol Sci. 2013 Jul 3;14(7):13842-75. doi: 10.3390/ijms140713842. Review.

7.

Near infrared fluorescent optical imaging for nodal staging.

Sampath L, Wang W, Sevick-Muraca EM.

J Biomed Opt. 2008 Jul-Aug;13(4):041312. doi: 10.1117/1.2953498. Review.

8.

Non-invasive molecular imaging of prostate cancer lymph node metastasis.

Pouliot F, Johnson M, Wu L.

Trends Mol Med. 2009 Jun;15(6):254-62. doi: 10.1016/j.molmed.2009.04.004. Epub 2009 May 29. Review.

9.

Lymph node staging using dedicated magnetic resonance contrast agents--the accumulation mechanism revisited.

Schütz G, Lohrke J, Pietsch H.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Mar-Apr;7(2):238-49. doi: 10.1002/wnan.1290. Epub 2014 Sep 29. Review.

PMID:
25266498
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk